Buy & Sell Soleno Therapeutics Inc (SLNO) – Soleno Therapeutics Inc Price Today
Key Stats
- $2.76BMarket Cap
- HealthSector
- -26%3M Drawdown
- $2.56BEnterprise Value
- -Dividend Yield
- 24 daysTypical Hold Time
Soleno Therapeutics Inc (SLNO) is currently valued at a market capitalization of $2.76B, with an enterprise value of $2.56B. Over the past 52 weeks, Soleno Therapeutics Inc has traded between a low of $30.05 and a high of $88.49, highlighting its annual price range. Over the past three months, Soleno Therapeutics Inc has recorded a drawdown of -26%, reflecting recent price volatility. On average, investors hold Soleno Therapeutics Inc for approximately 24 days, indicating typical investor behavior on the platform.
About Soleno Therapeutics Inc
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases. The company's lead product candidate, DCCR (Diazoxide Choline Extended-Release), is currently in late-stage clinical trials for the treatment of Prader-Willi Syndrome (PWS), a complex genetic disorder that causes a constant feeling of hunger (hyperphagia). Soleno is committed to addressing the significant unmet medical need in the PWS community.
Most Recent News
Norwegian court rejects banks' asset arrest request against Havila Shipping.
Borgarting Court of Appeal in Norway has denied the request by DNB Bank, Swedbank, and Danske Bank to arrest assets of Havila Shipping ASA. This decision follows earlier filings by the banks seeking to secure claims against the company. The ruling me...

Court dismisses bank petition to seize Havila Shipping assets in appeal case
Borgarting Court of Appeal has ruled against the petition by DNB Bank ASA, Swedbank AB, and Danske Bank to seize certain assets of Havila Shipping ASA. This dismissal means Havila Shipping retains control over the disputed assets, which could impact ...

Insurance analytics market to reach $72.39B by 2035, driven by AI, cloud, and fraud detection tech.
The global insurance analytics market is projected to grow from USD 17.60 billion in 2025 to USD 72.39 billion by 2035, at a CAGR of 15.19%. Growth is fueled by the adoption of AI, cloud computing, and big data, which help insurers reduce fraud, unde...
